A detailed history of Amundi transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Amundi holds 14,990 shares of RDY stock, worth $212,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,990
Previous 15,073 0.55%
Holding current value
$212,858
Previous $1.15 Million 3.66%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$75.41 - $84.21 $6,259 - $6,989
-83 Reduced 0.55%
14,990 $1.19 Million
Q2 2024

Aug 14, 2024

SELL
$68.26 - $76.19 $58,840 - $65,675
-862 Reduced 5.41%
15,073 $1.15 Million
Q1 2024

May 15, 2024

SELL
$67.36 - $77.59 $5.47 Million - $6.3 Million
-81,207 Reduced 83.6%
15,935 $1.17 Million
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $3.77 Million - $4.1 Million
58,678 Added 152.55%
97,142 $6.76 Million
Q3 2023

Nov 14, 2023

BUY
$61.9 - $72.77 $588,050 - $691,315
9,500 Added 32.8%
38,464 $2.57 Million
Q2 2023

Aug 14, 2023

BUY
$53.34 - $63.11 $112,014 - $132,531
2,100 Added 7.82%
28,964 $1.83 Million
Q1 2023

May 15, 2023

SELL
$51.63 - $56.93 $474,996 - $523,756
-9,200 Reduced 25.51%
26,864 $1.53 Million
Q4 2022

Feb 14, 2023

BUY
$51.15 - $57.45 $629,145 - $706,635
12,300 Added 51.76%
36,064 $1.87 Million
Q3 2022

Nov 14, 2022

SELL
$49.9 - $57.32 $1.88 Million - $2.16 Million
-37,700 Reduced 61.34%
23,764 $1.28 Million
Q2 2022

Aug 15, 2022

BUY
$49.62 - $58.13 $635,136 - $744,064
12,800 Added 26.3%
61,464 $3.52 Million
Q1 2022

May 16, 2022

SELL
$48.27 - $65.25 $853,944 - $1.15 Million
-17,691 Reduced 26.66%
48,664 $2.76 Million
Q4 2021

Feb 14, 2022

SELL
$59.5 - $67.25 $1.09 Million - $1.23 Million
-18,300 Reduced 21.62%
66,355 $4.21 Million
Q3 2021

Nov 15, 2021

BUY
$60.19 - $75.29 $1.11 Million - $1.39 Million
18,400 Added 27.77%
84,655 $5.51 Million
Q2 2021

Aug 16, 2021

BUY
$62.12 - $74.2 $4.12 Million - $4.92 Million
66,255 New
66,255 $4.87 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.36B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.